MARX Biotech Co., Ltd. (TPEX: 7731)
Taiwan
· Delayed Price · Currency is TWD
7.42
-0.17 (-2.24%)
Nov 21, 2024, 11:40 AM CST
MARX Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 94.46 | 152.83 | 27.73 | 0.18 |
Cash & Short-Term Investments | 97.96 | 152.83 | 27.73 | 0.18 |
Cash Growth | -21.26% | 451.09% | 15479.78% | - |
Accounts Receivable | 131.52 | 98.42 | 54.95 | - |
Other Receivables | 2.24 | 4.62 | - | - |
Receivables | 133.76 | 103.04 | 54.95 | - |
Inventory | 95.45 | 70 | 12 | - |
Prepaid Expenses | 19.65 | 13.98 | 0.83 | - |
Other Current Assets | 3.58 | 3.19 | 0.56 | - |
Total Current Assets | 350.4 | 343.04 | 96.07 | 0.18 |
Property, Plant & Equipment | 12.32 | 4.26 | 4.73 | - |
Long-Term Investments | - | - | - | 13.5 |
Goodwill | 5.37 | 5.37 | - | - |
Other Intangible Assets | 29.45 | 30.1 | - | - |
Long-Term Deferred Tax Assets | 5.14 | 4.92 | 1.94 | 0.09 |
Other Long-Term Assets | 10.77 | 7.15 | 0.45 | 0.03 |
Total Assets | 413.46 | 394.85 | 103.19 | 13.8 |
Accounts Payable | 14.07 | 23.72 | 5.26 | - |
Accrued Expenses | 28.75 | 39.77 | 12.98 | 0.5 |
Short-Term Debt | - | - | 10 | - |
Current Portion of Leases | 5.44 | 1.26 | 2.97 | - |
Current Income Taxes Payable | - | - | 3.41 | - |
Current Unearned Revenue | 107.74 | 25.08 | 2.28 | - |
Other Current Liabilities | 8.69 | 11.2 | 4.6 | 0.16 |
Total Current Liabilities | 164.69 | 101.04 | 41.5 | 0.66 |
Long-Term Leases | 2.3 | 0.62 | 0.87 | - |
Long-Term Deferred Tax Liabilities | 0.23 | 0.2 | 0.08 | - |
Total Liabilities | 167.22 | 101.86 | 42.45 | 0.66 |
Common Stock | 124.51 | 124.51 | 40.8 | 8.05 |
Additional Paid-In Capital | 172.46 | 186.03 | 17.98 | 3.21 |
Retained Earnings | -50.74 | -17.55 | 1.95 | 1.89 |
Shareholders' Equity | 246.24 | 292.99 | 60.73 | 13.14 |
Total Liabilities & Equity | 413.46 | 394.85 | 103.19 | 13.8 |
Total Debt | 7.74 | 1.88 | 13.84 | - |
Net Cash (Debt) | 90.22 | 150.94 | 13.89 | 0.18 |
Net Cash Growth | -19.23% | 986.39% | 7705.62% | - |
Net Cash Per Share | 0.19 | 0.36 | 0.04 | 0.01 |
Filing Date Shares Outstanding | 498.06 | 498.06 | 163.21 | 32.18 |
Total Common Shares Outstanding | 498.06 | 498.06 | 163.21 | 32.18 |
Working Capital | 185.71 | 242.01 | 54.57 | -0.48 |
Book Value Per Share | 0.49 | 0.59 | 0.37 | 0.41 |
Tangible Book Value | 211.41 | 257.52 | 60.73 | 13.14 |
Tangible Book Value Per Share | 0.42 | 0.52 | 0.37 | 0.41 |
Machinery | 5.2 | 2.7 | 1.03 | - |
Construction In Progress | - | 0 | 0.02 | - |
Leasehold Improvements | 1.28 | 1.1 | 0.44 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.